Effect of thyroid-stimulating hormone in 68Ga-DOTATATE PET/CT of radioiodine-refractory thyroid carcinoma-Reference-Cited by-同舟云学术

Effect of thyroid-stimulating hormone in 68Ga-DOTATATE PET/CT of radioiodine-refractory thyroid carcinoma

Published:2018-05 Issue:5 Volume:39 Page:441-450
ISSN:0143-3636
Container-title:Nuclear Medicine Communications
language:en
Short-container-title:

Author:

Almeida Ludmila S.,Araújo Maidane C.,Zantut-Wittmann Denise E.,Assumpção Lígia V.,Souza Thiago F.,Silva Cleide M.,Argenton Juliana L.,Santos Allan O.,Mengatti Jair,Ramos Celso D.,Etchebehere Elba C.

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Radiology, Nuclear Medicine and imaging,General Medicine

Reference45 articles.

1. Prognostic value of thyroglobulin serum levels and 131I whole-body scan after initial treatment of low-risk differentiated thyroid cancer;Menéndez Torre;Thyroid,2004

2. Phantoms in the assay tube: heterophile antibody interference in serum thyroglobulin assays;Preissner;J Clin Endocrinol Metab,2003

3. Possible explanations for patients with discordant findings of serum thyroglobulin and 131I whole-body scanning;Ma;J Nucl Med,2005

4. Staging and treatment of differentiated thyroid with radiolabeled somatostatin analogs;Teunissen;Trends Endocrinol Metab,2006

5. Relationship between expression of the sodium/iodide symporter and 131I uptake in recurrent lesions of differentiated thyroid carcinoma;Min;Eur J Nucl Med,2001

Cited by 10 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. 68Ga-DOTATATE PET/CT Versus 18F-FDG PET/CT in TENIS Syndrome: A Head-to-Head Comparison With Elevated and Suppressed TSH Levels in Papillary Thyroid Carcinoma—A Pilot Study;Clinical Nuclear Medicine;2024-09-12

2. Somatostatin receptor imaging of thyroid tissue and differentiated thyroid cancer using gallium-68-labeled radiotracers—a review of clinical studies;Endocrine;2024-03-18

3. Radiojodrefraktärer Schilddrüsenkrebs;Nuklearmedizin bei endokrinen Erkrankungen;2024

4. Radioiodine adjuvant therapy in differentiated thyroid cancer: An update and reconsideration;Frontiers in Endocrinology;2022-11-30

5. Radioiodine Refractory Thyroid Cancer;Nuclear Medicine in Endocrine Disorders;2022